Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02530073 · ClinicalTrials.gov registry record · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
A NA study of Congenital Diaphragmatic Hernias, sponsored by Connecticut Children's Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02530073 is a NA study of Congenital Diaphragmatic Hernias that is actively recruiting participants, run by Connecticut Children's Medical Center. The registered enrollment target is 15 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02530073, a NA study of Congenital Diaphragmatic Hernias, is actively recruiting participants, sponsored by Connecticut Children's Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
Conditions Studied
Interventions
- DEVICE Fetoscopic Endoluminal Tracheal Occlusion (FETO)
Study Locations (1)
Connecticut
- Connecticut Children's Medical Center - Hartford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2015-09 |
| Est. Completion | 2030-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02530073
The ClinicalTrials.gov registry entry for NCT02530073 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Connecticut Children's Medical Center, which has 55 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Congenital Diaphragmatic Hernias appearing as the primary indexed condition, and to 1 intervention - of which Fetoscopic Endoluminal Tracheal Occlusion (FETO) is the first listed.
NCT02530073 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT02530073 about?
NCT02530073 is a clinical study titled "Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH". The rationale for fetal therapy in severe congenital diaphragmatic hernia (CDH) is to restore adequate lung growth for neonatal survival.
What is the current status of trial NCT02530073?
This trial is currently recruiting. It is a NA study. The enrollment target is 15 participants. The study started on 2015-09. Estimated completion is 2030-08.
What conditions does trial NCT02530073 study?
This clinical trial studies the following conditions: Congenital Diaphragmatic Hernias.
What interventions are being tested in trial NCT02530073?
The interventions under investigation include: Fetoscopic Endoluminal Tracheal Occlusion (FETO) (DEVICE).
Who is sponsoring clinical trial NCT02530073?
This trial is sponsored by Connecticut Children's Medical Center, which has 55 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02530073 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.